US Broker Ratings

Investor Outlook: Premier, Inc. (PINC) Faces a Challenging Path with Zero Upside Potential

Premier, Inc. (NASDAQ: PINC) stands at a pivotal moment as it navigates the complex terrain of the healthcare sector. Specializing in health information services, Premier offers..

IDEAYA Biosciences, Inc. (IDYA) Stock Analysis: A 54% Potential Upside in the Precision Medicine Oncology Space

IDEAYA Biosciences, Inc. (NASDAQ: IDYA) is making waves in the biotechnology sector with its precision medicine approach to oncology. Headquartered in South San Francisco, IDEAYA is..

MannKind Corporation (MNKD): Analyst Consensus Points to 62.62% Potential Upside for Biotech Innovator

MannKind Corporation (NASDAQ: MNKD), a prominent player in the biotechnology sector, is drawing considerable attention from investors, thanks to its promising innovations in chronic disease care..

OPKO Health, Inc. (OPK) Stock Analysis: Exploring a 191.67% Potential Upside

Investors looking for opportunities in the healthcare sector should pay close attention to OPKO Health, Inc. (NASDAQ: OPK), a dynamic player in the diagnostics and pharmaceuticals..

Evolent Health, Inc (EVH) Investor Outlook: A 216% Potential Upside Amidst Current Challenges

Evolent Health, Inc (NYSE: EVH) stands at a pivotal crossroads, offering a tantalizing potential upside of 216.35% according to analyst ratings. This figure alone is enough..

Aurinia Pharmaceuticals Inc (AUPH): Investor Outlook and Analyst Consensus Reveal Promising 14.71% Upside

Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH), a prominent player in the biotechnology sector, has captured investor attention with its promising portfolio aimed at addressing autoimmune diseases. Headquartered..

MiMedx Group, Inc (MDXG) Stock Analysis: Exploring the 100% Potential Upside in Healthcare Biotech

MiMedx Group, Inc (NASDAQ: MDXG) is capturing investor interest with its impressive growth potential in the healthcare biotechnology sector. Known for its innovative use of placental..

Mineralys Therapeutics, Inc. (MLYS) Stock Analysis: Exploring a 60% Potential Upside in Biotech Innovation

Mineralys Therapeutics, Inc. (NASDAQ: MLYS), a notable player in the biotechnology sector, is capturing investor attention with its promising potential upside of 60.29%. With a market..

NovoCure Limited (NVCR) Stock Analysis: A Look at Its 139% Potential Upside

NovoCure Limited (NASDAQ: NVCR), a key player in the healthcare sector specializing in medical devices, presents a compelling case for investors with its robust potential upside...

Pulse Biosciences, Inc. (PLSE) Stock Analysis: Riding a Wave of Innovation with a 7.39% Upside Potential

Pulse Biosciences, Inc. (NASDAQ: PLSE), a trailblazer in the field of bioelectric medicine, has been making waves with its innovative technologies that offer promising solutions in..

Perrigo Company plc (PRGO) Stock Analysis: Evaluating a 46.65% Upside Potential for Healthcare Investors

Perrigo Company plc (NYSE: PRGO) is an intriguing player in the healthcare sector, specifically within the Drug Manufacturers – Specialty & Generic industry. Headquartered in Dublin,..

Beam Therapeutics Inc. (BEAM) Stock Analysis: A Biotech Innovator with 73% Potential Upside

Beam Therapeutics Inc. (NASDAQ: BEAM), a pioneering biotechnology company headquartered in Cambridge, Massachusetts, is capturing investor attention with its promising genetic medicine pipeline and significant potential..

Integra LifeSciences Holdings C (IART) Stock Analysis: Exploring 41.81% Potential Upside

Integra LifeSciences Holdings Corporation (NASDAQ: IART) operates at the intersection of innovation and healthcare within the medical devices industry. As a U.S.-based company with a market..

Aveanna Healthcare Holdings Inc (AVAH): Investor Outlook and Potential 39.77% Upside

Aveanna Healthcare Holdings Inc (AVAH) is capturing the attention of investors with its promising potential upside of nearly 40%. Based in Atlanta, Georgia, Aveanna operates as..

Azenta, Inc. (AZTA) Stock Analysis: Exploring a 29.75% Potential Upside in the Healthcare Sector

Azenta, Inc. (NASDAQ: AZTA) is making waves in the healthcare sector, particularly within the medical instruments and supplies industry. With a market capitalization of $1.37 billion,..

ARS Pharmaceuticals, Inc. (SPRY) Stock Analysis: A 194% Upside Potential in the Biotech Sector

ARS Pharmaceuticals, Inc. (NASDAQ: SPRY) is drawing significant attention from investors with its impressive potential upside of 194.52%, according to recent analyst ratings. As a biopharmaceutical..

SS Innovations International (SSII) Stock Analysis: Examining an Impressive 192.5% Revenue Growth in the Medical Device Sector

SS Innovations International Inc. (SSII), a burgeoning force in the healthcare sector, operates in the medical devices industry, showcasing revolutionary advancements in surgical robotics. Headquartered in..

Disc Medicine, Inc. (IRON) Stock Analysis: Evaluating a 66% Upside Potential in Biotechnology

Disc Medicine, Inc. (NASDAQ: IRON), a clinical-stage biopharmaceutical company, is capturing the attention of investors with its promising pipeline of treatments aimed at serious hematologic diseases...

Kestra Medical Technologies (KMTS) Investor Outlook: 53% Revenue Surge and 8% Upside Potential

Investors looking for opportunities in the healthcare sector might want to pay close attention to Kestra Medical Technologies, Ltd. (KMTS). This innovative company, headquartered in Kirkland,..

Privia Health Group, Inc. (PRVA) Investor Outlook: Unpacking a 44.48% Potential Upside in the Healthcare Sector

Privia Health Group, Inc. (NASDAQ: PRVA), a prominent name in the healthcare sector, is capturing investor attention with a striking potential upside of 44.48%. Operating as..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds